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Abstract
Mycobacterium tuberculosis is an obligate human pathogen capable of persisting in individual
hosts for decades. To determine whether antigenic variation and immune escape contribute to the
success of M. tuberculosis, we determined and analyzed 22 genome sequences representative of
the global diversity of the M. tuberculosis complex (MTBC). As expected, we found that essential
genes in MTBC were more evolutionarily conserved than non-essential genes. Surprisingly
however, most of 491 experimentally confirmed human T cell epitopes showed little sequence
variation and exhibited a lower ratio of non-synonymous to synonymous changes than essential
and non-essential genes. These findings are consistent with strong purifying selection acting on
these epitopes, and imply that MTBC might benefit from recognition by human T cells.
Infection with Mycobacterium tuberculosis causes enormous worldwide morbidity and
mortality; there were more cases of tuberculosis in 2007 (the last year for which data are
available) than at any prior point in world history1. Among the factors that contribute to the
continued growth of tuberculosis as a global health problem are the efficiency of human-to-
human transmission by the aerosol route, the ability of the causal agent M. tuberculosis to
persist and to progress despite development of host immune responses, and the absence of a
vaccine with reliable efficacy in preventing transmission of the infection. Moreover, while
attempts to control tuberculosis through improved identification and treatment of infectious
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cases have been successful in some settings, similar approaches in other contexts have
resulted in increasing rates of resistance to available anti-tuberculosis drugs2. Therefore,
new approaches to controlling tuberculosis are essential and would greatly benefit from an
improved understanding of the biology of the bacteria and their interactions with their
human hosts. In particular, understanding the factors that drive the evolution of M.
tuberculosis and allow it to evade host defences, may suggest unique opportunities to
develop novel strategies against tuberculosis.
Human tuberculosis is caused by Mycobacterium tuberculosis and Mycobacterium
africanum, which are members of the M. tuberculosis complex (MTBC). In addition to these
human-adapted pathogens, MTBC includes various animal-adapted forms, such as
Mycobacterium bovis, Mycobacterium microti, and Mycobacterium pinnipedii3. To
characterize the extent and nature of the forces acting to diversify MTBC, we and others
have applied several approaches to phylogenetic analysis of multiple clinical isolates from
geographically diverse sources. Using single nucleotide polymorphisms (SNPs)3-6 or large
sequence polymorphisms (LSPs)7-9 as genetic markers resulted in congruent groupings of
human-adapted MTBC into six major lineages and consistent geographical associations for
each of these lineages10. In addition, these studies found strong evidence for a clonal
population structure of MTBC, without evidence of ongoing horizontal gene transfer.
Analysis of SNPs in a total of 7 megabases of DNA sequence from 89 genes in 108 isolates
of MTBC provided strong evidence that MTBC originated in Africa, and underwent
population expansion and diversification following ancient human migrations out of Africa,
followed by global spread and return to Africa of three particularly successful MTBC
lineages through recent waves of travel, trade, and conquest3. Taken together, these studies
have revealed that MTBC has undergone genetic diversification that corresponds to patterns
of human migration, suggesting that distinct lineages have co-evolved with distinct human
populations7. Moreover, they indicate that further understanding of the mechanisms and
consequences of the interactions between MTBC and its human host can be obtained
through comparative genomic analyses.
Host-pathogen co-evolution is characterised by reciprocal adaptive changes in interacting
species11. Host immune pressure and associated parasite immune evasion are key features
of this process often referred to as an ‘evolutionary arms-race’12-13. Studies in human
pathogenic viruses, bacteria, and protozoa have revealed that genes encoding antigens tend
to be highly variable as a consequence of diversifying selection to evade host
immunity14-17. However, whether similar evolutionary mechanisms operate in MTBC, and
whether the bacteria undergo antigenic variation in response to host immune pressure, is
unknown.
Immunity to tuberculosis in humans, nonhuman primates, and mice depends on T
lymphocytes18. Among human T lymphocyte subsets, CD4+ T cells are clearly essential for
protective immunity to MTBC, as demonstrated by the observation that the incidence of
active tuberculosis in people infected with HIV is inversely proportional to the number of
circulating CD4+ T cells19. In addition to CD4+ T cell responses, humans infected with
MTBC develop antigen-specific CD8+ T cell responses20, and MTBC antigen-specific
human CD8+ T cells lyse infected cells and contribute to killing of intracellular MTBC21.
Therefore, there is strong evidence that the adaptive immune system represented by CD4+
and CD8+ T cells, is an important mechanism for host recognition and control of MTBC.
Recognition of foreign antigens by T lymphocytes depends on binding of short peptide
fragments (termed epitopes) derived by proteolysis of foreign proteins, to MHC (major
histocompatibility; in humans termed HLA (human leukocyte antigen)) proteins on the
surface of macrophages and dendritic cells; CD4+ T cells recognize peptide epitopes bound
to MHC/HLA class II; CD8+ T cells recognize peptide epitopes bound to MHC/HLA class I.
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To obtain a better understanding of the effects of human T cell recognition on the diversity
of MTBC, and to test the hypothesis that MTBC uses antigenic variation as one mechanism
of evading elimination by human immune responses, we determined the genome sequences
of 21 phylogeographically diverse strains of MTBC and used those genome sequences to
analyze the diversity of 491 experimentally verified human T cell epitopes. This analysis
produced the unexpected finding that the known human T cell epitopes are highly conserved
relative to the rest of the MTBC genome. These results provide evidence that the
relationship between MTBC and its human hosts may differ from that of a classical
evolutionary arms-race, and suggest that development of new approaches to control of
tuberculosis must take into account the possibility that certain human immune responses
may actually benefit MTBC.
RESULTS
A Genome-wide Phylogeny of Human-adapted MTBC
A total of 22 mycobacterial strains were included in this work. To study the sequence
diversity of T cell antigens in MTBC, we used Illumina next-generation DNA sequencing to
generate nearly complete genome sequences from 20 strains representative of the six main
human MTBC lineages, and one strain of Mycobacterium canettii which is the closest
known outgroup of MTBC3,22 (Table 1). In addition, we used the published genome
sequence of the H37Rv laboratory strain of M. tuberculosis as a common reference23. For
each of the 21 strains newly sequenced, a mean of 6.8 million sequence reads with a mean
length of 51 base pairs were generated and mapped to the H37Rv reference genome. On
average, the reads covered 98.9% of the 4.4 Mb reference genome (Table 1). The regions
not covered primarily included members of the highly GC-rich and repetitive PE/PPE gene
families24. A total of 32,745 SNPs were identified, corresponding to an average of 1 SNP
call for every 3 kb of sequence generated. We used a total of 9,037 unique SNPs (i.e. SNPs
that occurred in one or several strains) to derive a genome-wide phylogeny of 22 strains
(Fig. 1, Supplementary Fig. 1). Six main lineages could be distinguished with high statistical
support. These lineages were completely congruent to the strain groupings previously
defined based on genomic deletion analysis and multilocus sequencing3,7,10. The perfect
congruence between these different phylogenetic markers further corroborates the highly
clonal population structure of MTBC and lack of ongoing horizontal gene transfer in this
organism25. Because of the comprehensive nature of genome-scale data, a higher degree of
phylogenetic resolution could be achieved compared to all previous studies. In this new
phylogeny the brown and green lineages (also known as Mycobacterium africanum) are the
most basal groups when compared to the M. canettii outgroup. M. africanum is highly
restricted to West Africa for reasons that remain unclear8. However, the fact that the two M.
africanum lineages represent the most ancestral forms of human MTBC reinforces the
notion that human MTBC originated in Africa3,7.
Evolutionary Conservation Across Gene Categories
We used these genome sequence data and the phylogeny derived from them to compare the
genetic diversity in antigens and other experimentally determined gene classes. For
comparisons across different gene categories, we divided our dataset into three gene sets,
including ‘essential genes’, ‘non-essential genes’, and ‘antigens’ (Supplementary Fig. 2,
Supplementary Tables 1 and 2). Antigens were defined based on the presence of 491
experimentally confirmed human T cell epitopes (Supplementary Table 3), which were
compiled through the Immune Epitope Database (IEDB) initiative26. The ‘essential’ gene
category was defined based on genome-wide analyses of transposon insertion mutants that
were defective for the ability to grow on Middlebrook 7H11 agar, or in the spleens of
intravenously-infected mice, published previously27-28. We excluded from this analysis
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genes belonging to the PE/PPE gene family24 and those related to mobile elements as they
are difficult to study using current next-generation DNA sequencing technologies (total
genes excluded: 273/3,990 (6.8%) genes annotated in the H37Rv reference genome;
Supplementary Table 4).
Based on evolutionary theory and findings in other bacteria29, one would expect that in
contrast to non-essential genes, the essential genes in MTBC will be under stronger
purifying selection and thus more evolutionary conserved. In support of this notion, we
observed that on average essential genes harboured less nucleotide diversity than non-
essential genes (Fig. 2; Mann-Whitney U test p<0.002). We then compared the rates of
synonymous and non-synonymous SNPs in the essential and non-essential gene categories.
The synonymous and non-synonymous changes were derived by comparison to the most
likely recent common ancestor of MTBC, which we inferred based on our new genome-
wide phylogeny (Fig. 1, Supplementary Fig. 1). Because MTBC harbours little sequence
diversity, it was necessary to analyze the distribution of synonymous and non-synonymous
SNPs based on gene concatenates rather than individual genes. The two measures of
distribution we used were based on the number of non-redundant SNPs across all 21 MTBC
strains (dN/dS based on Measure A in Table 2 and Fig. 3), and on the individual pairwise
comparisons between each strain and the inferred most likely recent common ancestor (dN/
dS based on Measures B in Table 2). From these analyses, we found that the dN/dS
measures for essential genes were significantly lower than for non-essential genes (Measure
A in Fig. 3; Measure B in Table 2, Mann-Whitney U test p<0.0001). Taken together, these
data show that in MTBC essential genes are more evolutionary conserved than non-essential
genes.
Because MTBC interacts with humans through antigen-specific CD4+ or CD8+ T-cells, we
would expect T cell antigens to be among the most diverse genes in the genome. Particularly
when invoking a co-evolutionary arms-race and associated immune evasion, we would
anticipate these antigens to be under diversifying selection and to be more variable than
other genes in order to escape T cell recognition. However, when we analyzed the
nucleotide diversity in 78 experimentally confirmed human T cell antigens (Supplementary
Table 2), we found that they were on average not more diverse than essential genes (Fig. 2,
Mann-Whitney U test p=0.12). Moreover, we found that the dN/dS measures in these
antigens also resembled those of essential genes (Measure A in Fig. 3; Measure B in Table
2, Mann-Whitney U test p=0.77). Thus, human T cell antigens in MTBC do not appear to be
under diversifying selection. Instead, purifying selection appears to be the driving selection
pressure in these genes.
T Cell Epitopes are Hyperconserved
T cell antigens consist of epitope regions that interact with human T cells, and non-epitope
regions which are not targets of T cell recognition. Hence, we decided to study these regions
separately. To this end, we generated a separate concatenate of the epitope regions and
another concatenate of all corresponding non-epitope regions. Because little data is currently
available in the IEDB with respect to whether these 491 epitopes are recognized by CD4+ or
CD8+ T cells, we analyzed them as one class. If immune escape was driving antigen
evolution to evade T cell recognition in MTBC, we would expect non-synonymous changes
to accumulate in epitope regions, leading to a high dN/dS. Contrary to this expectation
however, the overall dN/dS of the epitope regions was 0.53, which was still similar to
essential genes and lower than non-essential genes (Table 2, Fig. 3). Moreover, when we
analyzed the distribution of amino acid replacements in individual epitopes we found that
the large majority (95%) of the 491 epitopes showed no amino acid change (Fig. 4). Only
five epitopes, contained in esxH, pstS1, and Rv1986, harboured more than one variable
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position (Supplementary Table 5). The higher number of amino acid substitutions in these
five epitopes may reflect ongoing immune evasion, but further investigation is needed to
determine whether the observed changes are due to immune pressure, other selection
pressure(s), or mere random genetic drift3. Because these five epitopes were clear outliers
compared to the large majority of T cell epitopes analyzed here, we repeated our dN/dS
analysis after excluding the three antigens harbouring the five outlier epitopes. Our analysis
revealed that the epitope regions had the lowest dN/dS of all gene categories (Table 2, Fig.
3). Furthermore, when we compared the proportion of non-redundant non-synonymous
changes in epitope and non-epitope regions, we found that epitopes were less likely than
non-epitopes to harbour changes at non-synonymous sites (Measure A in Table 2, χ2,
p<0.05), whereas no difference was observed at synonymous sites (Table 2, χ2, p=0.89).
To further corroborate our finding of hyperconservation of human T cell epitopes in MTBC,
we repeated our analysis using a data set from a previous study in which 89 individual genes
were sequenced in 99 human-adapted strains representative of the six major global lineages
of MTBC3. Sixteen of these 89 genes belonged to the T cell antigens analyzed here,
including two of the three outlier antigens esxH and pstS13. Analysis of this additional
dataset of 16 antigens in 99 MTBC strains revealed an overall dN/dS for the epitope regions
of 0.74. However, after excluding the two outlier antigens, the dN/dS dropped to 0.46,
which was again lower than the genome-based dN/dS values for essential and non-essential
genes (Fig. 3).
Taken together, our findings strongly suggest that a large proportion of the MTBC genome
known to interact with human T cells is highly conserved and under as strong, or perhaps
even stronger, purifying selection than essential genes.
DISCUSSION
In this study of 22 MTBC genomes, we demonstrate that, as expected, essential genes are
more conserved than non-essential genes. These results are in agreement with a previous
study which analyzed a single genome30. Surprisingly, however, we found that the large
majority of the currently known T cell antigens are as conserved as essential genes.
Furthermore, the epitope regions of these antigen genes are the most highly conserved
regions we studied. This observation, that the regions of the genome that interact with the
human adaptive immune system appear to be under even stronger purifying selection than
essential genes, is inconsistent with a classical model of an evolutionary arms-race.
It is possible that the known human T cell epitopes that we found to be hyperconserved
represent a select subset of all of the human T cell epitopes encoded in the genome, and that
certain approaches to epitope identification have favoured discovery of hyperconserved
epitopes in MTBC. For example, since most, if not all of the epitope discovery efforts to
date have utilized proteins and/or peptide sequences of strains from one lineage (lineage 4)
and T cells from humans that are likely to have been infected by strains of other lineages,
the assays used may have been especially suited to identification of hyperconserved and/or
cross-reactive epitopes. While further investigation using alternative approaches to epitope
discovery may reveal that variable epitopes that exhibit evidence of positive selection exist
in the MTBC, it is likely that the large number of epitopes that we examined will remain a
significant subset of the total, and that future vaccine development efforts will need to
account for the possibility that immune recognition of certain epitopes may actually provide
a net benefit to the bacteria.
Lack of antigenic variation and immune evasion has been reported for a number of other
human pathogens, including RNA viruses such as measles, mumps, rubella, and influenza
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type C31. Theoretical studies have suggested that the absence of immune escape variants in
these viruses might be due to structural constraints in viral proteins or negative mutational
effects leading to reduced infectivity or transmission31. While we cannot exclude the
possibility that structural and functional constraints that are independent of T cell
recognition contribute to hyperconservation of the regions encoding MTBC peptides
recognized by human T cells, one important characteristic of the aformentioned viral
pathogens is that they spread among young and immunologically naive hosts, which might
eliminate the need for immune evasion31. Moreover, infection by these viruses usually
results in acute disease, followed by elimination of the infection through adaptive immunity,
and acquisition of lifelong immunity against re-infection. This further indicates that these
viruses are specialized pathogens of immunologically naive hosts. By contrast, MTBC
causes chronic and often lifelong infections, and adaptive immunity is usually unable to
completely clear the infection18. Furthermore, tuberculosis patients are prone to re-
infection32, and mixed infections are also increasingly recognized33. These observations
suggest that the biological basis for the lack of antigenic variation in MTBC reported here
differs from what has been proposed for antigenically homogeneous RNA viruses31. In
addition, we determined that the fraction of hyperconserved T cell epitopes of the MTBC
that are derived from essential genes is indistinguishable from the frequency of essential
genes in the MTBC genome as a whole (18% versus 21%, respectively; χ2 = 0.28, p =
0.59), indicating that our results were not skewed by over-representation of T cell epitopes
in essential genes. Moreover, the T cell epitopes that we analyzed are present in genes from
diverse gene ontologies, and the representation of five main gene categories (defined based
on the NCBI Categories of Orthologous Groups (COG)) was no different in the T cell
antigens when compared to the genome overall (χ2 with 4 degrees of freedom = 5.8, p =
0.21; Supplementary Table 6). Hence the only identifiable common property of these
regions is their recognition by human T lymphocytes. These findings suggest that T
lymphocyte recognition is an important factor in hyperconservation of these sequences, and
that other structural or functional constraints are unlikely to fully account for the lack of
sequence variation in these domains.
Our data suggest that T cell epitopes in MTBC are under strong selection pressure to be
maintained, perhaps because the immune response they elicit in humans, which are essential
for survival of an individual host, might partially work towards the pathogen’s benefit. One
potential mechanism of benefit to MTBC from human T cell recognition is that human T
cell responses are essential for MTBC to establish latent infection. This notion is supported
by the fact that CD4+ T cell-deficient HIV-positive individuals progress rapidly to active
disease after infection, rather than to sustain prolonged periods of latent tuberculosis34.
Latent infection mediated by host T cell responses, with subsequent reactivation to active
disease often occurring decades after initial infection, is a key characteristic of human
tuberculosis, and might have evolved as a way for MTBC to transmit to later generations of
susceptible hosts35. In addition, there is evidence that T cell responses may contribute
directly to human-to-human transmission of MTBC. In particular, cavitary tuberculosis,
which generates secondary cases more efficiently than other disease forms36, rarely occurs
in CD4+ T cell-deficient HIV-positive individuals, and the frequency of cavitary lung
lesions in HIV-infected patients with tuberculosis is directly correlated with the number of
peripheral CD4+ T cells37. While the mechanisms of lung cavitation in tuberculosis are
poorly understood, these observations suggest that CD4+ T cells directly or indirectly
mediate tissue damage in tuberculosis, and together with our finding of epitope
hyperconservation indicate that certain T cell responses may be detrimental to the host and
beneficial to the pathogen. Hence our findings suggest that MTBC takes advantage of host
adaptive immunity to increase its likelihood of spread, and that the benefits of enhanced
transmission exceed the costs of within-host cellular immune responses to these epitopes. In
this manner, MTBC may resemble HIV, for which there is evidence that virulence has
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evolved, not to maximize replication of the virus within individual hosts, but to maximize
the likelihood of its transmission38. Whether T cell responses to other epitopes, or whether
specific T cell subsets (e.g. Th17 versus Th1) that benefit the host and not the bacteria can
be identified will require additional studies in humans.
One limitation of this study was the exclusion of PE/PPE genes because of technical
reasons. Some of these genes are known to vary and to be cell-surface exposed, which has
lead to the hypothesis they might be involved in antigenic variation24. However, no direct
evidence for this has yet been presented. Future work will need to clarify the function and
evolution of PE/PPE genes. By contrast, all the T cell antigens included in this study have
been experimentally confirmed26. Furthermore, some of them are being targeted by new
tuberculosis diagnostics and vaccines39. Our findings thus have important implications for
the development of these new tools. On the one hand, the fact that MTBC harbours little
sequence diversity in T cell antigens will facilitate the development of diagnostics that are
universally applicable across geographical regions where MTBC strains differ8. On the
other hand, the possibility that the immune responses induced by vaccine antigens might
partially benefit the pathogen suggests current efforts in vaccine research should be
broadened. Most disturbing is the suggestion that vaccine induced immunity against these
conserved epitopes may perversely increase transmission. In this respect, it is interesting to
note that the currently available tuberculosis vaccine Bacille-Calmette-Guerin (BCG), which
is a live vaccine based on an attenuated from of M. bovis, offers no protection against
pulmonary tuberculosis in adults40. More importantly, some clinical trials of BCG have
even reported an increased risk of tuberculosis in vaccinees compared to unvaccinated
individuals41. Thus, in contrast to standard reverse vaccinology, in which the least variable
antigens of a genome are targeted42, research into new tuberculosis vaccines should explore
more variable regions of the MTBC genome.
While most of the T cell epitopes anlyzed here were highly conserved, five epitopes in three
antigens harboured a larger number of amino acid changes. The fact that the dN/dS measure
dropped sharply after excluding these outlier antigens from the analysis further supports the
notion that they are indeed outliers compared to the other antigens. One of these outlier
antigens, esxH (Rv0288, also known as TB10.4) is a member of a gene family known to
encode a Type VII secretion system43. Importantly, this antigen is being considered as new
vaccine antigen against tuberculosis39. Thus even though most of the other vaccine antigens
analyzed here are conserved, our finding that this particular vaccine antigen harbours a
comparatively high number of amino acid substitutions across a panel of global MTBC
isolates, suggests that strain diversity should be considered during further development of
the new vaccine candidates containing esxH8.
We detected significant differences in dN/dS between essential, non-essential, and antigenic
genes. However, the individual dN/dS values remain high when compared to most other
bacteria44. Such a high dN/dS was reported previously for MTBC, and has been linked to
reduced selective constraint against slightly deleterious mutations3. It was proposed that the
serial transmission bottlenecks associated with patient-to-patient transmission in MTBC
could lead to an increase in random genetic drift compared to the forces of natural selection.
Our new data show that even though the strength of purifying selection in MTBC might be
reduced overall compared to other bacteria, it clearly is still acting on and capable of
differentiating between gene categories.
In summary, we show that T cell epitopes of MTBC are highly conserved, and do not reflect
any ongoing evolutionary arms-race or immune-evasion. Instead, the patterns observed
might be indicative of a distinct evolutionary strategy of immune-subversion developed by
this highly successful pathogen. Other intracellular bacteria such as Salmonella enterica
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serovar Typhi exhibit a similar lack of antigenic variation45, suggesting comparable
mechanisms might exist in other pathogens with a similar lifestyle.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Neighbour-joining phylogeny based on 9,037 variable common nucleotide positions across
21 human M. tuberculosis complex genome sequences. The tree is rooted with M. canettii,
the closest known outgroup. Node support following 1,000 bootstrap replications is
indicated. Branches are coloured according to the six main phylogeographic lineages of
MTBC defined previously3,7-8. Highly congruent topologies were obtained by Maximum
likelihood and Bayesian inference (Supplementary Fig. 1).
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Figure 2.
Average gene-by-gene nucleotide diversity across three gene classes. Boxplot indicating
median (horizontal line), interquartile range (box), and minimum and maximum values
(whiskers).
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Figure 3.
Ratio of the rates of synonymous and non-synonymous substitutions (dN/dS) in various
gene classes of MTBC. Overall dN/dS was calculated based on the number of non-
redundant synonymous and non-synonymous changes after comparing each of the 21 MTBC
genomes to the inferred most likely recent common ancestor of MTBC. This shows that
essential genes are more conserved than non-essential genes, and that antigens are as
conserved as essential genes. Figures for the epitope- and non-epitope regions refer to the
calculations after excluding the three outlier antigens esxH, pstS1, and Rv1986.
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Figure 4.
Number of variable amino acid positions in 491 human T cell epitopes of MTBC. This
demonstrates the remarkable lack of genetic variability among the regions of the genome
that interact with the human immune system.
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